CIK 0001124105
- Accelerated filer
- Smaller reporting company
GYRE THERAPEUTICS, INC.
Sign in to watch- Ticker
- GYRE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562020050
- Phone
- +1 858-284-0115
- Business address
- 12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
- Former names
- CATALYST BIOSCIENCES, INC., TARGACEPT INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-06-28 | USMAN NASSIM Director | Option exercise 10b5-1 | +3,452 | $6.93 | $24K | 5,088 |
| 2024-06-28 | USMAN NASSIM Director | Sale 10b5-1 | −3,452 | $12.00 | $41K | 1,636 |
| 2024-06-28 | USMAN NASSIM Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −3,452 | 278,200 | ||
| 2024-05-01 | USMAN NASSIM Director | Option exercise 10b5-1 | +20,000 | $6.93 | $139K | 21,636 |
| 2024-05-01 | USMAN NASSIM Director | Sale 10b5-1 | −14,900 | $13.86 | $207K | 6,736 |
| 2024-05-01 | USMAN NASSIM Director | Sale 10b5-1 | −5,000 | $14.90 | $75K | 1,736 |
| 2024-05-01 | USMAN NASSIM Director | Sale 10b5-1 | −100 | $15.63 | $2K | 1,636 |
| 2024-05-01 | USMAN NASSIM Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 281,652 | ||
| 2024-04-01 | USMAN NASSIM Director | Option exercise 10b5-1 | +20,000 | $6.93 | $139K | 21,636 |
| 2024-04-01 | USMAN NASSIM Director | Sale 10b5-1 | −20,000 | $16.15 | $323K | 1,636 |
| 2024-04-01 | USMAN NASSIM Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 301,652 | ||
| 2024-03-15 | USMAN NASSIM Director | Option exercise 10b5-1 | +20,000 | $6.93 | $139K | 21,636 |
| 2024-03-15 | USMAN NASSIM Director | Sale 10b5-1 | −20,000 | $17.26 | $345K | 1,636 |
| 2024-03-15 | USMAN NASSIM Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,000 | 321,652 | ||
| 2023-10-31 | USMAN NASSIM Director | Grant or award · Stock Option (Right to Buy) | +341,652 | 341,652 | ||
| 2023-10-31 | USMAN NASSIM Director | Grant or award · Stock Option (Right to Buy) | +1,866 | 1,866 | ||
| 2023-08-31 | USMAN NASSIM President & CEO | Returned to the company | −24.54 | 0 | ||
| 2023-08-31 | USMAN NASSIM President & CEO | Returned to the company | −8.46 | 0 | ||
| 2023-08-31 | USMAN NASSIM President & CEO | Returned to the company | −1.17 | 0 | ||
| 2022-08-09 | USMAN NASSIM President & CEO | Purchase | +3,250 | $0.47 | $2K | 24,541 |
Page 1 of 2 · 31 trades